AI assistant
BIO-TECHNE Corp — Director's Dealing 2021
May 4, 2021
30718_dirs_2021-05-04_69bc106e-606f-4d89-8cd2-f3aa130a8d1b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2021-05-01
Reporting Person: Kelderman Kim (Pres. Diagnostics & Genom)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-05-01 | Common Stock | M | 1667 | — | Acquired | 2512 | Direct |
| 2021-05-01 | Common Stock | F | 856 | $427.49 | Disposed | 1656 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-05-01 | Restricted Stock Units | $ | M | 1667 | Disposed | Common Stock (1667) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Options (Right to Buy) | $150.78 | 2025-05-01 | Common Stock (2652) | 2652 | Direct |
| Stock Options (Right to Buy) | $150.78 | 2025-05-01 | Common Stock (7348) | 7348 | Direct |
| Restricted Stock Units | $ | Common Stock (1691) | 1691 | Direct | |
| Stock Options (Right to Buy) | $177.32 | 2025-08-08 | Common Stock (12044) | 12044 | Direct |
| Stock Options (Right to Buy) | $177.32 | 2025-08-08 | Common Stock (9033) | 9033 | Direct |
| Restricted Stock Units | $ | Common Stock (2363) | 2363 | Direct | |
| Stock Options (Right to Buy) | $190.41 | 2026-08-07 | Common Stock (11961) | 11961 | Direct |
| Stock Options (Right to Buy) | $190.41 | 2026-08-07 | Common Stock (15948) | 15948 | Direct |
| Restricted Stock Units | $ | Common Stock (2015) | 2015 | Direct | |
| Stock Options (Right to Buy) | $267.87 | 2027-08-05 | Common Stock (8991) | 8991 | Direct |
| Stock Options (Right to Buy) | $267.87 | 2027-08-05 | Common Stock (11988) | 11988 | Direct |
| Stock Options (Right to Buy) | $267.87 | 2027-08-05 | Common Stock (8325) | 8325 | Direct |
| Stock Options (Right to Buy) | $267.87 | 2027-08-05 | Common Stock (8325) | 8325 | Direct |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
F2: 1,667 restricted stock units vest on 5/1/2021.
F3: Options to purchase 663 shares vest on each of 5/1/2019, 5/1/2020, 5/1/2021 and 5/1/2022.
F4: Options to purchase 1,837 shares vest on each of 5/1/2019, 5/1/2020, 5/1/2021 and 5/1/2022.
F5: Vests in full or in part on 8/8/2021 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F6: Options to purchase 3,011 shares vest on each of 8/8/2019, 8/8/2020, 8/8/2021 and 8/8/2022.
F7: Vests in full or in part on 8/7/2022 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F8: Options to purchase 3,987 shares vest on each of 8/7/2020, 8/7/2021, 8/7/2022 and 8/7/2023.
F9: Vests in full or in part on 8/5/2023 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F10: Options to purchase 2,997 shares vest on each of 8/5/2021, 8/5/2022, 8/5/2023 and 8/5/2024.
F11: Options to purchase 2,775 shares vest on each of 8/5/2021, 8/5/2022 and 8/5/2023.
F12: Vests in full on the date performance of certain product revenue goals during the period of fiscal 2021-2023 is certified by the Administrator, in no event earlier than 8/5/2021